![]() |
Volumn 342, Issue 6155, 2013, Pages 206-207
|
GWAS to therapy by genome edits?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HEMOGLOBIN F;
TRANSCRIPTION FACTOR;
BCL11A PROTEIN, HUMAN;
CARRIER PROTEIN;
NUCLEAR PROTEIN;
DISEASE TREATMENT;
GENETIC ANALYSIS;
GENOME;
GENOMICS;
HEMOGLOBIN;
DISEASE PREDISPOSITION;
ERYTHROID CELL;
GENE DELETION;
GENE EXPRESSION;
GENE REPLACEMENT THERAPY;
GENE THERAPY;
GENETIC ASSOCIATION;
GENETIC ENGINEERING AND GENE TECHNOLOGY;
GLOBIN GENE;
HEMOGLOBINOPATHY;
HERITABILITY;
HUMAN;
HYPERSENSITIVITY;
LYMPHOID CELL LINE;
NONHUMAN;
PHENOTYPE;
PRIORITY JOURNAL;
QUANTITATIVE TRAIT LOCUS;
SHORT SURVEY;
SICKLE CELL ANEMIA;
SINGLE NUCLEOTIDE POLYMORPHISM;
THALASSEMIA;
ANIMAL;
BIOSYNTHESIS;
ENHANCER REGION;
GENE EXPRESSION REGULATION;
GENETICS;
METABOLISM;
NOTE;
ANIMALS;
CARRIER PROTEINS;
ENHANCER ELEMENTS, GENETIC;
ERYTHROID CELLS;
FETAL HEMOGLOBIN;
GENE EXPRESSION REGULATION;
HEMOGLOBINOPATHIES;
HUMANS;
NUCLEAR PROTEINS;
|
EID: 84885587219
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.1245813 Document Type: Short Survey |
Times cited : (14)
|
References (15)
|